Siemens Healthcare names Hariharan Subramanian as MD

IMT News Desk
IMT News Desk
· 1 min read

Takes over the new role effective July 1, 2023, from Vivek Kanade, who takes over other responsibilities within the organisation

Hariharan Subramanian (49) has been named as the Managing Director of Siemens Healthcare Private Limited (SHPL), India, effective July 1, 2023. SHPL is the wholly owned subsidiary company of the global MedTech company, Siemens Healthineers listed in Frankfurt, Germany.

Subramanian leads the business for Siemens Healthineers India including, manufacturing, sales, distribution and strategy for ‘Zone India, comprising neighbouring countries like Bangladesh, Nepal, Sri Lanka, Bhutan and Maldives.

During his association of over 25 years with Siemens, Subramanian has held leadership positions in Finance, Business Administration, Enterprise Services, and Sales functions across Software engineering, IT Consulting, and Healthcare business. Before assuming responsibilities of Zone India in May 2023, he was the Head of Sales for the Diagnostic Imaging and Advanced Therapy businesses in India.

He has been leading the team in Zone India towards the common goal of pioneering breakthroughs in healthcare, for everyone, everywhere, so that therapy becomes more precise and affordable, value is at the heart of care delivery, patients are treated as consumers, healthcare becomes digital and in turn, we improve access to care.

Read Next

‘One Nation, One Emergency Helpline’ Proposal for Stroke Care Gains Momentum at FICCI Meet
News
April 16, 2026

‘One Nation, One Emergency Helpline’ Proposal for Stroke Care Gains Momentum at FICCI Meet

India’s stroke crisis demands urgent action, and the Indian Stroke Association (ISA) is leading the charge with a bold proposal for a unified national helpline. The ISA presented a comprehensive plan to strengthen stroke care delivery at a FICCI-hosted meeting attended by policymakers, healthcare leaders, and clinical experts. The plenary session, “Strengthening Stroke Care Delivery,” […]
Article by: IMT News Desk
Ivory raises fresh capital to strengthen deep tech offerings
News
April 16, 2026

Ivory raises fresh capital to strengthen deep tech offerings

Ivory, a brain health platform focused on early cognitive screening, has raised $1M in fresh funding, onboarding new investors to deepen its product, clinical and IP capabilities. The round saw participation from Draper Associates, a global venture capital firm with a strong focus on biotech and healthtech, along with SAGE Venture Fund, an AIF fund launched […]
Article by: IMT News Desk
Rubicon Research Enters Indian CNS Formulations Market with Strategic Acquisition
News
April 16, 2026

Rubicon Research Enters Indian CNS Formulations Market with Strategic Acquisition

Rubicon Research Limited today announced the acquisition of an 85% equity ownership in Arinna Lifesciences Limited from its current shareholders. With a portfolio of over 60 brands in chronic therapies, Arinna is one of the few domestic formulation companies principally focused on drugs treating conditions of the central nervous system (“CNS”) with more than 4,000 […]
Article by: IMT News Desk
MSN Laboratories Launches ‘SEMABEST, the First Integrated Made-in-India Semaglutide
News
April 16, 2026

MSN Laboratories Launches ‘SEMABEST, the First Integrated Made-in-India Semaglutide

MSN Laboratories has launched SEMABEST, its semaglutide brand, in the Indian market following approval from the Central Drugs Standard Control Organisation (CDSCO). SEMABEST is priced at nearly 50% lower than the innovator drug, significantly improving affordability and patient access. The therapy is available as a pre-filled pen for subcutaneous administration. In this evolving landscape, SEMABEST […]
Article by: IMT News Desk